大唐药业
(836433)
| 流通市值：13.14亿 | | | 总市值：19.86亿 |
| 流通股本：1.69亿 | | | 总股本：2.56亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 52,984,418.25 | 31,691,813.48 | 19,789,366.66 | 24,446,458.65 |
| 应收票据及应收账款 | 64,547,894.22 | 58,568,736.65 | 90,530,015.84 | 74,369,010.53 |
| 其中：应收票据 | 6,886,433.09 | 4,269,532.38 | 1,851,174 | 2,692,722.4 |
| 应收账款 | 57,661,461.13 | 54,299,204.27 | 88,678,841.84 | 71,676,288.13 |
| 应收款项融资 | 1,347,569.55 | 21,893,881.02 | 2,087,929.2 | 3,647,837.35 |
| 预付款项 | 13,337,299.51 | 15,400,400.2 | 11,676,628.65 | 9,177,858.85 |
| 其他应收款合计 | 400,123.4 | 602,284.46 | 313,563.9 | 260,291.46 |
| 存货 | 62,867,037.59 | 55,767,306.64 | 53,113,862.21 | 60,309,066.4 |
| 一年内到期的非流动资产 | 21,738,273.97 | 54,506,246.57 | - | - |
| 其他流动资产 | 566.78 | 138,446.07 | 208,911.26 | 397,650.45 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 222,536,121.07 | 238,569,115.09 | 177,720,277.72 | 177,942,364.82 |
| 非流动资产: | | | | |
| 长期应收款 | 506,526.37 | 506,526.37 | 506,526.37 | 506,526.37 |
| 固定资产 | 383,684,851.87 | 389,670,628.59 | 394,555,279.96 | 391,047,008.44 |
| 在建工程 | 1,095,172.98 | 1,150,887.92 | 1,422,598.19 | 7,893,462.48 |
| 使用权资产 | 1,885,513.86 | 1,917,113.95 | 1,963,501.32 | 2,009,888.69 |
| 无形资产 | 20,688,703.98 | 20,842,089.57 | 20,995,475.16 | 21,148,860.75 |
| 长期待摊费用 | 3,827,631.04 | 2,773,663.56 | 952,932.24 | 1,127,268.23 |
| 递延所得税资产 | 5,528,174.08 | 5,578,036.74 | 6,467,907.2 | 5,879,608.66 |
| 其他非流动资产 | 2,492,385.7 | 1,086,270 | 56,052,707.96 | 55,328,475.56 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 419,708,959.88 | 423,525,216.7 | 482,916,928.4 | 484,941,099.18 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 642,245,080.95 | 662,094,331.79 | 660,637,206.12 | 662,883,464 |
| 流动负债: | | | | |
| 短期借款 | 70,722,242.76 | 84,471,395.11 | 87,462,358.71 | 90,056,739.58 |
| 应付票据及应付账款 | 36,892,852.9 | 40,719,062.18 | 33,258,515.09 | 44,652,737.65 |
| 应付账款 | 36,892,852.9 | 40,719,062.18 | 33,258,515.09 | 44,652,737.65 |
| 合同负债 | 10,738,649.3 | 13,490,740.98 | 13,750,055.51 | 13,885,533.37 |
| 应付职工薪酬 | 5,242,162.03 | 6,597,952.17 | 4,081,410.64 | 3,314,922.45 |
| 应交税费 | 3,160,352.88 | 5,393,123 | 6,945,210.54 | 5,575,702.5 |
| 其他应付款合计 | 6,258,186.83 | 5,820,918.65 | 8,740,497.7 | 8,430,850.29 |
| 一年内到期的非流动负债 | 523,671.02 | 523,671.02 | 183,930.81 | 250,232.4 |
| 其他流动负债 | 5,933,161.84 | 2,689,704.86 | 1,944,890.6 | 1,083,829.15 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 139,471,279.56 | 159,706,567.97 | 156,366,869.6 | 167,250,547.39 |
| 非流动负债: | | | | |
| 租赁负债 | 603,081.79 | 682,452.74 | 1,189,385.31 | 1,189,385.31 |
| 长期应付款 | 407,249.94 | 407,249.94 | 407,249.94 | 407,249.94 |
| 递延收益 | 21,784,069.01 | 22,608,587.26 | 24,161,919.43 | 20,727,446.19 |
| 递延所得税负债 | 287,955.22 | 287,567.09 | 269,563.9 | 302,509.03 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 23,082,355.96 | 23,985,857.03 | 26,028,118.58 | 22,626,590.47 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 162,553,635.52 | 183,692,425 | 182,394,988.18 | 189,877,137.86 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 255,919,681 | 255,919,681 | 255,919,681 | 255,919,681 |
| 资本公积 | 128,961,697.08 | 128,961,697.08 | 128,961,697.08 | 128,961,697.08 |
| 盈余公积 | 33,361,972.94 | 33,361,972.94 | 32,198,080.59 | 32,198,080.59 |
| 未分配利润 | 61,448,094.41 | 60,158,555.77 | 61,162,759.27 | 55,926,867.47 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 479,691,445.43 | 478,401,906.79 | 478,242,217.94 | 473,006,326.14 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 479,691,445.43 | 478,401,906.79 | 478,242,217.94 | 473,006,326.14 |
| 负债和股东权益合计 | 642,245,080.95 | 662,094,331.79 | 660,637,206.12 | 662,883,464 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-25 | 2024-08-14 |
| 审计意见(境内) | | 标准无保留意见 | | |